YOO JIN CHONG: Open Payments
NPI 1831124650 · CARLSBAD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,896 in 60 payments from 15 companies in 2025. Trend: 2023 $1,429 · 2024 $972 · 2025 $1,896
Food & beverage: $1,896
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $570 |
| ABBVIE INC. | 10 | $330 |
| GlaxoSmithKline, LLC. | 7 | $242 |
| Janssen Pharmaceuticals, Inc | 5 | $143 |
| Abbott Laboratories | 1 | $121 |
| Lilly USA, LLC | 5 | $105 |
| Novo Nordisk Inc | 4 | $99 |
| Gilead Sciences, Inc. | 2 | $63 |
| Boston Scientific Corporation | 1 | $58 |
| Exact Sciences Corporation | 2 | $53 |
Products named: AIRSUPRA, BREZTRI, SPRAVATO, AREXVY, FREESTYLE LIBRE 3, UBRELVY, TRELEGY ELLIPTA, QULIPTA.
Industry payments across CA — which companies pay providers there.
